Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunotherapy in malignant melanoma].

L R Braathen1, R E Hunger, C U Brand

  • 1Dermatologische Klinik, Universität Bern.

Zentralblatt Fur Chirurgie
|December 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

New onset of sarcoidosis after COVID-19 infection.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

[Erratum to: Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2021
Same author

New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

[Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2021
Same author

Loss of Concurrent Regulation of the Expression of BIF-1, BAX, and Beclin-1 in Primary and Metastatic Melanoma.

Biochemistry. Biokhimiia·2020
Same journal

[Non-intubated VATS from the Perspective of Anesthesiology Perspective - Methods, Advantages, Risks].

Zentralblatt fur Chirurgie·2026
Same journal

[Treatment of Vocal Fold Paralysis].

Zentralblatt fur Chirurgie·2026
Same journal

Zentralblatt fur Chirurgie·2026
Same journal

Predictive Factors for Mediastinal Lymph Node Metastases in Patients with Non-small Cell Lung Cancer, as Detected by Video-assisted Mediastinoscopic Lymphadenectomy.

Zentralblatt fur Chirurgie·2026
Same journal

[Robotic Management of a Bile Leak After Cholecystectomy Caused by an Aberrant Bile Duct of the Hepatic Segments, Using a Combined Biliodigestive Anastomosis Incorporating the Cystic Duct Stump].

Zentralblatt fur Chirurgie·2026
Same journal

[Microvascular Reconstruction of the Laryngotracheal Junction].

Zentralblatt fur Chirurgie·2026
See all related articles

Malignant melanoma, a deadly skin cancer, is increasingly researched for new treatments. Immunotherapy using melanoma-specific peptides shows promise, but more potent vaccination strategies are needed for better outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Context:

  • Malignant melanoma is the deadliest skin tumor, with rising incidence and unsatisfactory treatment outcomes.
  • Current treatments include surgery, chemotherapy, and biological response modifiers, necessitating novel therapeutic strategies.

Purpose:

  • To explore the potential of immunotherapy targeting melanoma-specific antigenic peptides for treating malignant melanoma.
  • To review current research on generating T cell-mediated immune responses against melanoma.

Summary:

  • Identification of melanoma antigenic peptides (e.g., Melan-A, gp100) has opened avenues for targeted immunotherapy.
  • Various approaches, including dendritic cell vaccination and peptide immunization, have shown encouraging results in eliciting anti-melanoma immune responses.

Related Experiment Videos

  • Future advancements depend on developing more potent tumor-vaccine protocols.

    • Impact:

    • Advances in melanoma immunotherapy could lead to improved treatment efficacy and patient survival rates.
    • This research highlights the importance of peptide-based vaccines in the development of novel cancer therapies.